MERCK SERONO S.A., Appellant v. HOPEWELL PHARMA VENTURES, INC.

Functional Limitation, Claim Construction, and Obviousness: Bayer v. Mylan

WHEN AN APPARATUS CLAIM DEPENDS ON FUNCTIONING CLAIM TO DESCRIBE THE APPARATUS, WHAT THE DEVICE DOES AND HOW IT DOES IT ARE HIGHLY RELEVANT TO UNDERSTANDING WHAT THE DEVICE IS

The Federal Circuit’s First AIA Derivation Case

No Going Back!

SHOCKING – APPLICANT ADMITTED PRIOR ART SINKS OWN PATENT

Presumption of Validity Does Not Protect a Patent from Invalidity for Lack of Adequate Written Description

Federal Circuit’s Question of First Impression on the Patent Eligibility of Machine Learning

LESS HEIGHTENED STANDARD FOR THE NEXUS REQUIREMENT REGARDING THE LICENSES OFFERED AS OBJECTIVE INDICIA OF NONOBVIOUSNESS

CAFC Affirms Prosecution Disclaimer and Non-Infringement in ANDA Case